Publication
Title
The use of methotrexate in conservative treatment of placenta accreta spectrum disorders
Author
Abstract
Aim of the study: This article reports on a series of patients with placenta accreta spectrum (PAS) disorder who were treated conservatively with Methotrexate (MTX) administration with or without embolization. We investigate whether there is a place for MTX in conservative treatment of PAS. Methods: We present a single-center retrospective case series of five patients. In all patients, diagnosis was unexpected and not made prenatally. Conclusion: The benefits should be weighed against the possible drug toxicity. Today high-quality evidence is lacking. PAS covers a broad spectrum of pathology, standardization in prenatal and postnatal diagnosis can help to compare evidence on treatment.
Language
English
Source (journal)
The journal of maternal-fetal and neonatal medicine. - New York, N.Y., 2005, currens
Publication
Abingdon : Taylor & francis ltd , 2022
ISSN
1476-7058
DOI
10.1080/14767058.2021.1951211
Volume/pages
35 :25 (2022) , p. 7514-7517
ISI
000674860300001
Pubmed ID
34278931
Full text (Publisher's DOI)
UAntwerpen
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 30.07.2021
Last edited 02.10.2024
To cite this reference